Edition:
United States

Pulmatrix Inc (PULM.OQ)

PULM.OQ on NASDAQ Stock Exchange Global Market

0.34USD
22 Oct 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.34
Open
$0.35
Day's High
$0.36
Day's Low
$0.34
Volume
21,045
Avg. Vol
124,078
52-wk High
$2.16
52-wk Low
$0.28

Chart for

About

Pulmatrix, Inc. is a clinical stage biopharmaceutical company developing inhaled therapies to address serious pulmonary disease. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. In addition,... (more)

Overall

Beta: 2.02
Market Cap(Mil.): $43.07
Shares Outstanding(Mil.): 20.12
Dividend: --
Yield (%): --

Financials

  PULM.OQ Industry Sector
P/E (TTM): -- 85.35 33.64
EPS (TTM): -1.37 -- --
ROI: -104.24 0.18 14.27
ROE: -122.80 1.14 15.99

BRIEF-Pulmatrix Q1 Loss Per Share $0.24

* QTRLY LOSS PER SHARE $0.24 Source text for Eikon: Further company coverage:

May 11 2018

Earnings vs. Estimates